| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
5,734 |
4,920 |
$579K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
17,409 |
15,879 |
$551K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
3,031 |
2,565 |
$540K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,916 |
4,536 |
$326K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
13,427 |
11,908 |
$322K |
| 36415 |
Collection of venous blood by venipuncture |
9,081 |
5,543 |
$291K |
| 80053 |
Comprehensive metabolic panel |
11,344 |
8,622 |
$243K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,740 |
739 |
$233K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,126 |
3,406 |
$195K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,295 |
2,983 |
$186K |
| S0028 |
Injection, famotidine, 20 mg |
2,484 |
2,086 |
$181K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,158 |
345 |
$176K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,561 |
5,524 |
$170K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
11,386 |
8,337 |
$154K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,889 |
6,480 |
$146K |
| J3490 |
Unclassified drugs |
695 |
377 |
$135K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,235 |
2,709 |
$132K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,171 |
1,021 |
$108K |
| 81001 |
|
8,556 |
7,430 |
$103K |
| 87400 |
|
5,271 |
4,443 |
$91K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,202 |
1,948 |
$83K |
| 87070 |
|
3,393 |
3,068 |
$82K |
| 82962 |
|
6,454 |
2,244 |
$80K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
924 |
219 |
$79K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,839 |
2,361 |
$76K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
23,247 |
15,545 |
$75K |
| G0378 |
Hospital observation service, per hour |
9,694 |
3,805 |
$69K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,235 |
2,061 |
$58K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,079 |
1,724 |
$56K |
| 71045 |
Radiologic examination, chest; single view |
9,653 |
7,616 |
$53K |
| 71046 |
Radiologic examination, chest; 2 views |
3,538 |
3,015 |
$52K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,266 |
994 |
$51K |
| 81003 |
|
3,735 |
3,295 |
$48K |
| 84484 |
|
9,842 |
5,677 |
$43K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
721 |
659 |
$42K |
| 81025 |
|
3,110 |
2,934 |
$41K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
1,261 |
545 |
$41K |
| 96376 |
|
2,348 |
1,305 |
$35K |
| A9270 |
Non-covered item or service |
4,760 |
1,979 |
$33K |
| 83735 |
|
3,330 |
2,187 |
$33K |
| 76830 |
Ultrasound, transvaginal |
811 |
753 |
$33K |
| 85610 |
|
12,744 |
9,787 |
$32K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
8,763 |
6,531 |
$31K |
| 84100 |
|
2,161 |
1,456 |
$31K |
| 85730 |
|
12,305 |
9,485 |
$31K |
| 86850 |
|
3,654 |
2,928 |
$31K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,623 |
8,280 |
$31K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
921 |
572 |
$27K |
| 97535 |
Self-care/home management training, each 15 minutes |
850 |
561 |
$26K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,330 |
1,187 |
$26K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
969 |
831 |
$25K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
2,287 |
1,342 |
$25K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,237 |
6,085 |
$25K |
| 87040 |
|
4,043 |
2,231 |
$25K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,342 |
4,676 |
$25K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
249 |
179 |
$23K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,731 |
2,240 |
$22K |
| 82805 |
|
982 |
724 |
$22K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
607 |
145 |
$21K |
| 74018 |
|
786 |
721 |
$20K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
154 |
52 |
$20K |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,180 |
1,125 |
$20K |
| 76818 |
|
354 |
235 |
$19K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,425 |
1,986 |
$19K |
| 83880 |
|
2,373 |
1,846 |
$16K |
| 82550 |
|
5,553 |
4,155 |
$16K |
| 59025 |
Fetal non-stress test |
457 |
267 |
$16K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
897 |
737 |
$15K |
| J7050 |
Infusion, normal saline solution, 250 cc |
3,929 |
2,564 |
$14K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,251 |
1,851 |
$14K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,258 |
1,181 |
$13K |
| J2704 |
Injection, propofol, 10 mg |
2,213 |
1,819 |
$13K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,354 |
1,018 |
$13K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
983 |
749 |
$12K |
| 86900 |
|
3,721 |
2,985 |
$12K |
| 86901 |
|
3,731 |
2,983 |
$11K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,796 |
2,198 |
$10K |
| 73610 |
|
379 |
330 |
$10K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,302 |
1,057 |
$10K |
| 97161 |
|
771 |
593 |
$10K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
275 |
249 |
$10K |
| 80076 |
|
3,750 |
3,182 |
$9K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
564 |
509 |
$9K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
108 |
89 |
$9K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,430 |
2,037 |
$9K |
| 73562 |
|
446 |
325 |
$9K |
| J1815 |
Injection, insulin, per 5 units |
680 |
269 |
$9K |
| 80061 |
Lipid panel |
2,412 |
1,934 |
$9K |
| 76801 |
|
810 |
716 |
$9K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,636 |
5,500 |
$8K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
894 |
757 |
$8K |
| 84702 |
|
2,646 |
2,234 |
$8K |
| 83690 |
|
4,533 |
3,852 |
$8K |
| 73630 |
|
485 |
399 |
$8K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
209 |
150 |
$8K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
746 |
585 |
$8K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
235 |
187 |
$6K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
172 |
154 |
$6K |
| 87088 |
|
4,554 |
4,006 |
$6K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
205 |
169 |
$6K |
| 93971 |
|
336 |
254 |
$6K |
| 73030 |
|
394 |
294 |
$5K |
| 83605 |
|
2,069 |
1,399 |
$5K |
| 72100 |
|
637 |
532 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,586 |
1,240 |
$4K |
| C9113 |
Injection, pantoprazole sodium, per vial |
1,407 |
970 |
$4K |
| 74019 |
|
135 |
132 |
$4K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
748 |
576 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,805 |
1,473 |
$4K |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
74 |
55 |
$4K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
579 |
435 |
$4K |
| 82607 |
|
686 |
534 |
$4K |
| 82150 |
|
1,553 |
1,371 |
$4K |
| 93970 |
|
374 |
273 |
$4K |
| 87077 |
|
1,581 |
1,297 |
$4K |
| 87045 |
|
78 |
74 |
$4K |
| A4217 |
Sterile water/saline, 500 ml |
541 |
317 |
$3K |
| 73110 |
|
118 |
100 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
833 |
648 |
$3K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
839 |
665 |
$3K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
249 |
246 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,525 |
2,398 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,350 |
2,901 |
$3K |
| 76641 |
|
162 |
62 |
$3K |
| 71250 |
|
413 |
277 |
$3K |
| 73130 |
|
117 |
94 |
$2K |
| 84703 |
|
3,207 |
2,952 |
$2K |
| 87205 |
|
761 |
576 |
$2K |
| 29125 |
|
58 |
53 |
$2K |
| C1769 |
Guide wire |
322 |
216 |
$2K |
| 97162 |
|
66 |
54 |
$2K |
| 87186 |
|
1,438 |
1,197 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
798 |
495 |
$2K |
| 96367 |
|
207 |
139 |
$2K |
| 87420 |
|
522 |
513 |
$2K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
597 |
474 |
$2K |
| 72170 |
|
339 |
235 |
$2K |
| 83540 |
|
381 |
308 |
$2K |
| 12011 |
|
50 |
42 |
$2K |
| 70486 |
|
192 |
143 |
$1K |
| 82728 |
|
498 |
399 |
$1K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
264 |
158 |
$1K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
876 |
739 |
$1K |
| 82746 |
|
450 |
356 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,121 |
1,004 |
$967.56 |
| 72040 |
|
19 |
14 |
$940.25 |
| 85379 |
|
910 |
811 |
$916.52 |
| 82731 |
|
13 |
13 |
$886.79 |
| 84112 |
|
14 |
14 |
$753.94 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
59 |
50 |
$736.70 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
65 |
46 |
$644.17 |
| 93880 |
|
89 |
64 |
$591.94 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,345 |
1,711 |
$590.54 |
| 77080 |
|
119 |
89 |
$587.17 |
| 93976 |
|
27 |
25 |
$565.26 |
| 73080 |
|
34 |
28 |
$551.32 |
| J1940 |
Injection, furosemide, up to 20 mg |
66 |
39 |
$538.58 |
| 85045 |
|
59 |
41 |
$538.58 |
| 84439 |
|
274 |
213 |
$519.91 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
331 |
270 |
$424.45 |
| 92523 |
|
13 |
12 |
$422.68 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
101 |
75 |
$414.89 |
| J2060 |
Injection, lorazepam, 2 mg |
755 |
586 |
$399.68 |
| 73590 |
|
49 |
39 |
$394.93 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
80 |
63 |
$376.43 |
| 76770 |
|
31 |
25 |
$350.84 |
| 77066 |
Tomosynthesis, mammo |
24 |
13 |
$349.27 |
| 84132 |
|
59 |
53 |
$343.48 |
| 84550 |
|
300 |
214 |
$307.43 |
| 73502 |
|
65 |
41 |
$307.27 |
| 90714 |
|
105 |
84 |
$211.12 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
105 |
85 |
$202.48 |
| 12002 |
|
16 |
12 |
$194.04 |
| 86403 |
|
18 |
16 |
$170.64 |
| 88304 |
|
46 |
37 |
$118.72 |
| 86141 |
|
596 |
546 |
$104.47 |
| 82248 |
|
195 |
155 |
$87.02 |
| 86738 |
|
97 |
82 |
$65.36 |
| 84145 |
|
141 |
104 |
$25.21 |
| 88313 |
|
12 |
12 |
$18.66 |
| 86140 |
|
499 |
468 |
$13.22 |
| 83550 |
|
131 |
112 |
$8.09 |
| 83615 |
|
179 |
138 |
$5.90 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
116 |
96 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
144 |
116 |
$0.00 |
| J1741 |
Injection, ibuprofen, 100 mg |
18 |
13 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
34 |
25 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
44 |
40 |
$0.00 |
| 88342 |
|
41 |
24 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
315 |
179 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
56 |
40 |
$0.00 |
| 85651 |
|
40 |
33 |
$0.00 |
| 88300 |
|
37 |
26 |
$0.00 |
| J0456 |
Injection, azithromycin, 500 mg |
13 |
12 |
$0.00 |
| 87081 |
|
16 |
14 |
$0.00 |
| 86592 |
|
30 |
25 |
$0.00 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
15 |
12 |
$0.00 |
| 99001 |
|
1,105 |
1,018 |
$0.00 |
| 99218 |
|
127 |
60 |
$0.00 |
| 85384 |
|
236 |
163 |
$0.00 |
| J1956 |
Injection, levofloxacin, 250 mg |
221 |
151 |
$0.00 |
| 87185 |
|
27 |
26 |
$0.00 |
| 00840 |
|
15 |
12 |
$0.00 |
| 82140 |
|
23 |
15 |
$0.00 |
| 87899 |
|
115 |
74 |
$0.00 |
| 85007 |
|
13 |
12 |
$0.00 |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
26 |
12 |
$0.00 |
| J3105 |
Injection, terbutaline sulfate, up to 1 mg |
19 |
15 |
$0.00 |